Korro Bio, Inc.
KRRO · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | – | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -25.3% | -42.7% | 12.3% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 100% | 100% | 100% | 100% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -1,548.8% | -1,779.1% | -933.1% | -959.4% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -1,657% | -1,765.1% | -917.1% | -933.5% |
| EPS Diluted | -1.92 | -2.74 | -2.49 | -2.26 |
| % Growth | 29.9% | -10% | -10.2% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |